Trial Profile
Phase I trial of fostamatinib in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Feb 2009
Price :
$35
*
At a glance
- Drugs Fostamatinib (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Rigel Pharmaceuticals
- 05 Feb 2009 New trial record.